ZBTB24: Potential Drug Target Or Biomarker (G9841)

Target Name: ZBTB24

NCBI ID: G9841

ZBTB24

ZBTB24: Potential Drug Target Or Biomarker

ZBTB24 (KIAA0441) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the ZBTB family, which contains several similar proteins that are involved in cell-cell adhesion and survival signaling. ZBTB24 has been shown to play a role in a variety of physiological processes, including the regulation of blood pressure, the development and progression of cancer, and the regulation of neurodegeneration. As a result, ZBTB24 has generated a lot of interest as a potential drug target or biomarker.

The ZBTB family of proteins was first identified in the late 1990s based on the analysis of genomic and transcriptomic data. These proteins are characterized by the presence of a characteristic Z-shaped molecular domain, which is composed of a series of amino acids that are often held in a specific arrangement. ZBTB24 is one of the most well-studied members of the ZBTB family, and it has been shown to be involved in a variety of cellular processes.

One of the most significant functions of ZBTB24 is its role in cell-cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. In the brain, adhesion is important for the formation of neural circuits and the development of neural stem cells. ZBTB24 is involved in the regulation of cell-cell adhesion by promoting the interaction between adhesion molecules and the cytoskeleton. This interaction allows cells to stick together and form tissues that are functional and organized.

In addition to its role in cell-cell adhesion, ZBTB24 has also been shown to be involved in the regulation of neurodegeneration. Neurodegeneration is the progressive loss of brain cells that can result from a variety of conditions, including Alzheimer's disease and Parkinson's disease. ZBTB24 has been shown to play a role in the regulation of neurodegeneration by promoting the survival of neurons and glial cells, which are important for the maintenance of neural function.

ZBTB24 has also been shown to be involved in the regulation of blood pressure. Blood pressure is an important factor that regulates blood flow to the body's tissues and organs. ZBTB24 has been shown to play a role in the regulation of blood pressure by controlling the activity of ion channels in blood vessels. This regulation allows the body to maintain a stable blood pressure and ensures that blood is delivered to the body's tissues and organs in a timely manner.

Finally, ZBTB24 has also been shown to be involved in the regulation of cancer progression. Cancer is a complex disease that can progress rapidly and is responsible for the majority of deaths in the world. ZBTB24 has been shown to play a role in the regulation of cancer progression by promoting the growth and survival of cancer cells. This regulation allows cancer cells to spread and form tumors, which can be a deadly and invasive.

In conclusion, ZBTB24 is a protein that is involved in a variety of physiological processes in the body. Its role in cell-cell adhesion, neurodegeneration, blood pressure regulation, and cancer progression has generated a lot of interest as a potential drug target or biomarker. Further research is needed to fully understand the functions of ZBTB24 and its potential as a therapeutic agent.

Protein Name: Zinc Finger And BTB Domain Containing 24

Functions: May be involved in BMP2-induced transcription

The "ZBTB24 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZBTB24 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets